Assessment and medication management of paediatric obsessive-compulsive disorder.

about

Shame in the obsessive compulsive related disorders: a conceptual review.Rare Synaptogenesis-Impairing Mutations in SLITRK5 Are Associated with Obsessive Compulsive Disorder.Development and validation of the Youth Obsessive-Compulsive Symptoms Scale (YOCSS).

P2860

Q34614330-D70D27EF-1E69-4E70-92F8-45F242982AB5 Q36248953-9C3B71CB-F7A0-40E3-8555-CAF81D238068 Q49097482-AC1B44BD-C37B-4652-8EC3-86153493D377

P2860

Assessment and medication management of paediatric obsessive-compulsive disorder.

Item

http://www.wikidata.org/entity/Q48685331

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Assessment and medication management of paediatric obsessive-compulsive disorder.

@en

Assessment and medication management of paediatric obsessive-compulsive disorder.

@nl

type

Item

label

Assessment and medication management of paediatric obsessive-compulsive disorder.

@en

Assessment and medication management of paediatric obsessive-compulsive disorder.

@nl

prefLabel

Assessment and medication management of paediatric obsessive-compulsive disorder.

@en

Assessment and medication management of paediatric obsessive-compulsive disorder.

@nl

P1476

Assessment and medication management of paediatric obsessive-compulsive disorder

@en

P2093

Dianne Hezel

http://www.w3.org/2001/XMLSchema#string

S Evelyn Stewart

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder

A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder

White matter abnormalities in patients with obsessive-compulsive disorder and their first-degree relatives.

Long-term treatment of obsessive-compulsive disorder after an acute response: a comparison of fluoxetine versus placebo.

Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial.

Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder

Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.

D-cycloserine augmented exposure therapy for obsessive-compulsive disorder.

Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I).

P2888

11632860-000000000-00000

P304

881-893

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11632860-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrea C Stachon

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1026018769

http://www.w3.org/2001/XMLSchema#string

P698

22564131

http://www.w3.org/2001/XMLSchema#string

Assessment and medication management of paediatric obsessive-compulsive disorder.

about

P2860

P2860

Assessment and medication management of paediatric obsessive-compulsive disorder.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698